Evidence map›Paper›PMID 27813829›Full record

ReviewAnnual review of physiology2017

Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.

Keisuke Yanagida, Timothy Hla

Abstract readReview
In one paragraph

Review in Annual review of physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Regulatory T cell and endothelial cell crosstalk.Nature reviews. Immunology · 2025
    Review
  10. Article
  11. Article
  12. Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases.International journal of molecular sciences · 2024
    Review
  13. Article
  14. CD4CNS neuroscience & therapeutics · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Keisuke YanagidaVascular Biology Program, Department of Surgery, Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts 02115; email: Timothy.Hla@childrens.harvard.edu , Keisuke.Yanagida@childrens.harvard.edu.
Timothy HlaVascular Biology Program, Department of Surgery, Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts 02115; email: Timothy.Hla@childrens.harvard.edu , Keisuke.Yanagida@childrens.harvard.edu.

Funding

Pilot Study: POPULATION PHARMACOLOGYU54HL117798 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KOHANE, ISAAC S. · 2012 to 2016
$18.5M
THE ROLE OF ENDOCANNABINOIDS AND THEIR RECEPTORS IN COLORECTAL CANCERP01CA077839 · NCI · VANDERBILT UNIVERSITY · PI DUBOIS, RAYMOND N. · 1999 to 2016
$17.8M
Sphingolipid modulators of vascular growth & homeostasisR37HL067330 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HLA, TIMOTHY TUN · 2006 to 2015
$3.9M
Sphingosine 1-phosphate receptors in vascular homeostasis and pathologyR01HL089934 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HLA, TIMOTHY TUN · 2008 to 2016
$3.3M
Sphingolipid modulators of vascular growth &homeostasisR01HL067330 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HLA, TIMOTHY TUN · 2001 to 2005
$1.6M
NCI NIH HHS P01 CA077839NHLBI NIH HHS R01 HL067330NHLBI NIH HHS R01 HL089934NHLBI NIH HHS R37 HL067330NHLBI NIH HHS U54 HL117798
6 · The paper itself

Abstract

Vertebrates are endowed with a closed circulatory system, the evolution of which required novel structural and regulatory changes. Furthermore, immune cell trafficking paradigms adapted to the barriers imposed by the closed circulatory system. How did such changes occur mechanistically? We propose that spatial compartmentalization of the lipid mediator sphingosine 1-phosphate (S1P) may be one such mechanism. In vertebrates, S1P is spatially compartmentalized in the blood and lymphatic circulation, thus comprising a sharp S1P gradient across the endothelial barrier. Circulatory S1P has critical roles in maturation and homeostasis of the vascular system as well as in immune cell trafficking. Physiological functions of S1P are tightly linked to shear stress, the key biophysical stimulus from blood flow. Thus, circulatory S1P confinement could be a primordial strategy of vertebrates in the development of a closed circulatory system. This review discusses the cellular and molecular basis of the S1P gradients and aims to interpret its physiological significance as a key feature of the closed circulatory system.

Indexed as

AnimalsCardiovascular SystemHomeostasisHumansLysophospholipidsSphingosineLysophospholipidsSphingosinesphingosine 1-phosphateangiogenesisG protein-coupled receptorHDLimmune cell traffickinglipid chaperoneslipid mediatorssphingolipidvascular biology

Identifiers

PMID27813829
PMCPMC5500220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.